ARDX

Ardelyx (ARDX)

Ardelyx Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ARDX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/08	07:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/06	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/06	07:09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/04	21:57	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARDX	Ardelyx Inc
2024/05/31	05:02	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/22	21:02	GlobeNewswire Inc.	Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
2024/05/21	21:02	GlobeNewswire Inc.	Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults	NASDAQ:ARDX	Ardelyx Inc
2024/05/16	21:01	GlobeNewswire Inc.	Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)	NASDAQ:ARDX	Ardelyx Inc
2024/05/15	05:02	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/05/10	05:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/08	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/07	21:01	GlobeNewswire Inc.	Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference	NASDAQ:ARDX	Ardelyx Inc
2024/05/03	05:02	GlobeNewswire Inc.	Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARDX	Ardelyx Inc
2024/05/01	21:00	GlobeNewswire Inc.	Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings	NASDAQ:ARDX	Ardelyx Inc
2024/04/18	21:00	GlobeNewswire Inc.	Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024	NASDAQ:ARDX	Ardelyx Inc
2024/03/29	05:05	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/03/25	21:00	GlobeNewswire Inc.	Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	NASDAQ:ARDX	Ardelyx Inc
2024/03/13	05:35	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/03/06	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/02/29	08:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/02/27	22:00	GlobeNewswire Inc.	Ardelyx to Participate at the Cowen 44th Annual Health Care Conference	NASDAQ:ARDX	Ardelyx Inc
2024/02/23	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/02/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc